Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions.
Pantano F, Croset M, Driouch K, Bednarz-Knoll N, Iuliani M, Ribelli G, Bonnelye E, Wikman H, Geraci S, Bonin F, Simonetti S, Vincenzi B, Hong SS, Sousa S, Pantel K, Tonini G, Santini D, Clézardin P.
Pantano F, et al. Among authors: bonnelye e.
Oncogene. 2021 Feb;40(7):1284-1299. doi: 10.1038/s41388-020-01603-6. Epub 2021 Jan 8.
Oncogene. 2021.
PMID: 33420367
Free PMC article.